Use access key #2 to skip to page content.
$3.29 -0.06 (-1.79%)
11/21/2008 4:00 PM

Halozyme Therapeutics, Inc. (HALO)

CAPS Rating:
**

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating HALO

Add Stock to Watchlist

What the Community Thinks

Total Members

176 Outperforms
31 Underperforms
 

All-Stars

28 Outperforms
16 Underperforms
 

Wall Street

2 Outperforms
2 Underperforms
 

Members bullish on HALO are also bullish on:

Members bearish on HALO are also bearish on:

Ticker Tags

Biotechnology (230), Micro Cap (5043)
Suggest a tag

Halozyme Therapeutics, Inc. At A Glance

Current Price: $3.29
Last Trade Time: 11/21/2008 4:00 PM
Open: $3.43
Previous Close: $3.35
Daily Range: $2.84 - $3.43
52-Week Range: $3.31 - $8.50
Volume: 613,698
Market Cap: $272.84M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

HALO VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for HALO

More Headlines...

Top Bull Pitch

Recs

4

Halozyme Therapeutics, Inc. (HALO)

Avatar icemeta2 (44.41) Submitted: 3/16/07 8:18 AM

Just signed a $600 million deal with Roche, a $100+ million deal with Baxter, and has a drug comimg to market in 6 months, there are only 35 employees, production is jobbed out saving capital exp and mfg problems. The only stock I have that could be 20x in 3 years.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

5

Halozyme Therapeutics, Inc. (HALO)

Avatar davidmelnikov (< 20) Submitted: 12/19/06 10:20 AM

1. roche deal not that great.
2. stock overvalued
3. company exists of 19 employees
4. no disaster recovery in place, company can be wiped out.
5. to many pumpers/blogs bringing the stock price up for no reason.

Replies: 2 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 36 :   1 2 3 4 5 Next »

Recs

0

 (HALO)

Avatar TheHuney (82.20) Submitted: 11/05/08 4:44 AM : Underperform Start Price: $4.86 HALO Score: 8.73

Going on the zzlangerhans pitch.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HALO)

Avatar Tri3 (< 20) Submitted: 11/01/08 9:34 AM : Outperform Start Price: $4.76 HALO Score: -9.17

+

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HALO)

Avatar capeboy (< 20) Submitted: 10/05/08 12:42 PM : Outperform Start Price: $6.32 HALO Score: -18.72

New licensing partnerships and increasing sales of approved products will make this stock a good value in the medium term during uncertain markets.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HALO)

Avatar gdesignr (67.29) Submitted: 3/20/08 9:22 AM : Outperform Start Price: $6.15 HALO Score: -4.82

This stock seems to truly have a halo around it and should perform nicely as a mover and a shaker. Jump on now to cash in.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HALO)

Avatar icemeta (41.43) Submitted: 12/03/07 9:17 PM : Outperform Start Price: $7.46 HALO Score: -7.61

Explosive drug collaboration, $100 million cash, no debt, director just bought 20% of stock, incredible market opportunity, my largest position

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 36 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackMorganJos < 20 09/11/07 Underperform NS $9.17-64.12%-48.14%+15.98
TrackOppenheimer < 20 07/24/07 Outperform NS $9.28-64.55%-50.47%-14.07
TrackJimCramer 85.65 12/13/06 Underperform 3W $7.07-53.47%-46.75%+6.71
TrackJefferies < 20 12/01/06 Outperform NS $2.89+13.84%-46.04%+59.88

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links